Genmab — Maj 2019

[lahn1]

Kan en kapitaludvidelse være for modstå en overtagelse ?

[lahn1]

for at

[E_L]

i know questions have been asked before to Jan, if it wasnt possible to get a better US listing

[StockBull]

om 5 min ved vi om der er noget stort igang eller det bare er en teknisk justering

[E_L]

also, maybe it is no coincidence that this happens only recently after installing a new investor relations team. (but maybe it is )

[E_L]

IF it is ony a technical thing, they COULD even do this capital neutral by delisting Copenhagen shares (?)

[E_L]

so in short, i think it is a bit early to draw all kind of theories until they tell us more...

[jkj]

SL. siger at genmab ikke vil stige på denne nyhed. Det er positivt da han i 9 ud af 10 gange aldrig har ret i hans kurs spådomme på dagen.

[Jazzz]

Not really sure what the practical differences are between the two different kind of listings (ADS or ADR). In other words why make the change? Cant have anything to do with capital increase but maybe NY stock exchange users just prefers ADRs?

[Teller]

hvis den falder tilbage er det en klar købs mulighed.

[Teller]

ADS is the actual share trading, while the ADR represents a bundle of ADS

[StockBull]

https://play.borsen.dk/klip/5cee146e595ab4f00a332ecf/genmab_soeger_ny_boersnotering_i_usa_kan_hente_op_mod_en_halv_milliard_dollar.html

[StockBull]

avavavav

[StockBull]

suppleringsmulighed ?

[Helge_LarsenPI-redaktør]

Av?

[Teller]

Ja, markedet er ikke så god til usikkerhed

[jkj]

de bliver nød til at fortælle noget mere

[Vitus]

Usikkerhed/uvished vil altid give kurstab..

[Helge_LarsenPI-redaktør]

Alt er megarødt.

[Jazzz]

Ok. SL explains the possible reasons..so it must be expected future need of capital..